OncoMatch/Clinical Trials/Head & Neck Cancer (HNSCC)
Head & Neck Cancer (HNSCC) Clinical Trials
OncoMatch filters Head & Neck Cancer (HNSCC) trials by the molecular markers that determine eligibility — CD274, EGFR, PIK3CA, CDKN2A, and more. Enter your biomarker results to see only the trials you may qualify for.
Compare eligibility criteriaBiomarkers tested in Head & Neck Cancer (HNSCC) trials
These are the molecular markers most commonly required or evaluated in Head & Neck Cancer (HNSCC) eligibility criteria. OncoMatch extracts them from each trial's protocol and matches them against your test results.
Top recruiting Head & Neck Cancer (HNSCC) trials
Ranked by phase and number of US sites. See all trials matched to your profile →
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
National Cancer Institute (NCI)
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
Rakuten Medical, Inc.
Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell Carcinoma
Privo Technologies
A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Akeso
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Sun Yat-sen University
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
Shanghai Jiao Tong University School of Medicine
How OncoMatch finds Head & Neck Cancer (HNSCC) trials for you
AI reads the protocol
Every Head & Neck Cancer (HNSCC) trial on ClinicalTrials.gov has eligibility criteria written for regulators. OncoMatch uses large language models to extract the structured requirements — biomarkers, stage, prior therapy, and more — from that text.
You enter your results
Select Head & Neck Cancer (HNSCC) and mark your biomarker results — CD274, EGFR, PIK3CA — as positive, negative, or not tested. Your data never leaves your device.
See only relevant trials
Results filter instantly. Each trial shows exactly which criteria you meet, which you don't, and which need more information. Bring the list to your oncologist.